TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 288 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,676,070 | -2.6% | 302,267 | -1.0% | 0.06% | +5.5% |
| Q2 2023 | $4,798,714 | +3.1% | 305,456 | +8.1% | 0.06% | +1.9% |
| Q1 2023 | $4,655,880 | +2.9% | 282,517 | -2.6% | 0.05% | -3.6% |
| Q4 2022 | $4,526,543 | +18.0% | 290,163 | -1.9% | 0.06% | +12.0% |
| Q3 2022 | $3,835,000 | -7.3% | 295,706 | +0.3% | 0.05% | +4.2% |
| Q2 2022 | $4,138,000 | -0.8% | 294,799 | +1.2% | 0.05% | +20.0% |
| Q1 2022 | $4,172,000 | -4.1% | 291,402 | -8.7% | 0.04% | +11.1% |
| Q4 2021 | $4,351,000 | -17.5% | 319,305 | -0.8% | 0.04% | -20.0% |
| Q3 2021 | $5,274,000 | -3.3% | 322,022 | -0.7% | 0.04% | 0.0% |
| Q2 2021 | $5,456,000 | – | 324,229 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |